High-Dose Trivalent Inactivated Flu Vaccine May Improve Seroconversion Rate in RA
These results suggest that high-dose trivalent inactivated influenza vaccine may improve post-vaccine response in immunocompromised patients, including those with RA.
These results suggest that high-dose trivalent inactivated influenza vaccine may improve post-vaccine response in immunocompromised patients, including those with RA.
Treatment of psoriatic arthritis (PsA) with ixekizumab (IXE)—an IgG4 monoclonal antibody—significantly improves arthritis, dactylitis and enthesitis at 52-weeks